Mutual Fund

Fund Card

Nippon India Pharma Fund(G)

very highequitypharma & health care

486.92 4.71(0.98%) NAV as on 04 Feb 2025

-7.66 % 1 M

16.46 % 1 Y

18.68 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

Expenses Ratio :

1.80

As on 31 Dec, 2024

Age :

20 yrs 8 m

Since 05 06 ,2004

Exit Load :

AUM :

8,160.74 Crs

Lock-in :

1% on or before 1M, Nil after 1M

Investing Style :

Large Growth

Portfolio Price To Book Value :

8.48

Min. Investment :

SIP 100 & Lumpsum 5000

Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jan 31 ,2025

Others 1.36 %

Equity 98.64 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.01 %

Divi's Laboratories Ltd.9.23 %

Lupin Ltd.8.16 %

Cipla Ltd.5.62 %

Dr. Reddy's Laboratories Ltd.5.46 %

See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs	79.69
Hospital & Healthcare Services	17.92
Business Support	1.03

See All Sectors

5-YEARS HISTORY

Financial Year	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
NAV in Rs (as on 04-Feb-2025)	250.18	290.14	270.59	428.87	486.92
Net Assets(Rs Crores) (as on 04-Feb-2025)	4260.99	4931.89	4304.46	7125.28	8914.89
Scheme Returns(%)(Absolute)	77.36	14.83	-6.85	58.24	12.24
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	32/75	43/75	65/76	17/90	33/98

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity486.924.71(0.98%)NAV As on 04 Feb, 2025	05-Jun-2004Inception Date	8,160.74AUM In Cr.	16.46%1Y	18.68%3Y	25.21%5Y	20.67%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.096.90(1.66%)NAV As on 04 Feb, 2025	14-Jul-1999Inception Date	3,628.03AUM In Cr.	29.31%1Y	23.55%3Y	27.76%5Y	16.50%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.450.48(1.30%)NAV As on 04 Feb, 2025	13-Jul-2018Inception Date	5,320.29AUM In Cr.	29.99%1Y	23.27%3Y	28.49%5Y	22.26%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.710.44(1.51%)NAV As on 04 Feb, 2025	28-Dec-2015Inception Date	1,287.45AUM In Cr.	24.56%1Y	20.02%3Y	25.20%5Y	12.69%Since Inception